Noninvasive NESA Microcurrent Neuromodulation for Refractory Overactive Bladder in Women: A Triple-Blind, Randomized, Sham-Controlled Pilot Trial.

Medicina (Kaunas) · 2026 · PMC13208972 · PMID 42195189

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, when directly comparing NESA and sham groups, between-group differences in ICIQ-UI SF and B-SAQ outcomes did not reach statistical significance at the end of treatment ( Table 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.